Recruiting Liver Disease Studies in Palo Alto
TReatment for ImmUne Mediated PathopHysiology
TReatment for ImmUne Mediated PathopHysiology (TRIUMPH) is a multi-center, three arm, randomized, controlled trial of immunosuppressive therapy for children with acute liver failure. The study will de...
Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND)
The purpose of this study is to determine whether the investigational treatment (maralixibat) is safe and effective in pediatric and adult participants who have cholestatic liver disease with pruritus...
About Liver Disease Clinical Trials in Palo Alto
Chronic liver disease encompasses conditions that damage the liver over time, including cirrhosis, hepatitis, and fatty liver disease. The liver plays a crucial role in digestion, metabolism, and detoxification. Treatment depends on the cause and may include medications, lifestyle changes, or liver transplant.
There are currently 2 liver disease clinical trials recruiting participants in Palo Alto, CALIFORNIA. These studies are seeking a combined 253 participants. Research is being sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Mirum Pharmaceuticals, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Liver Disease Clinical Trials in Palo Alto — FAQ
Are there liver disease clinical trials in Palo Alto?
Yes, there are 2 liver disease clinical trials currently recruiting in Palo Alto, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Palo Alto?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you about next steps.
Are clinical trials in Palo Alto free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Palo Alto studies also compensate for your time and travel.
What liver disease treatments are being tested?
The 2 active trials in Palo Alto are testing new therapies including novel drugs, biologics, and treatment approaches for liver disease.
Data updated March 2, 2026 from ClinicalTrials.gov